Published in AIDS on September 01, 1992
Syphilis: mimicking yet another disease! Sex Transm Infect (2001) 0.75
Homosexual men, HIV, and sexual risk in 2001. Sex Transm Infect (2001) 0.75
False-positive neutralizable HIV antigens detected in organ transplant recipients. AIDS (1993) 0.75
Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med (1974) 5.73
Influence of dose and route of antigen injection on the immunological induction of T cells. J Exp Med (1974) 4.99
Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells. J Natl Cancer Inst (1973) 4.10
Immunopotentiation with BCG. I. Immune response to different strains and preparations. J Natl Cancer Inst (1973) 3.20
Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother (1998) 3.17
Feedback inhibition of specifically sensitized lymphocytes. J Exp Med (1974) 3.11
A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother (2000) 2.85
Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol (1994) 2.66
Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. FEMS Microbiol Lett (1995) 2.63
Pefloxacin as first-line treatment in nephrotic syndrome. Lancet (1992) 2.58
Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett (2000) 2.57
Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2. Antimicrob Agents Chemother (1996) 2.48
Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory. J Clin Microbiol (2004) 2.43
The modifying effect of BCG on the immunological induction of T cells. J Exp Med (1974) 2.30
An evaluation of the polymerase chain reaction amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis (1994) 2.26
Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b. Arch Dermatol (1996) 2.23
Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol Lett (1998) 2.09
Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis (1994) 1.94
Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol (2003) 1.91
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob Agents Chemother (1998) 1.85
Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements. Diabetes Care (1997) 1.83
Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis (1998) 1.79
Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. J Infect Dis (2000) 1.78
Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest (1994) 1.75
A stable form of delayed-type hypersensitivity. J Exp Med (1975) 1.68
An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci U S A (1997) 1.55
Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca. Antimicrob Agents Chemother (1995) 1.53
CD4+ lymphocytopenia without HIV in patient with cryptococcal disease. Lancet (1991) 1.52
beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca. Antimicrob Agents Chemother (1996) 1.47
Leprosy and BCG in southern Vietnam. Lancet (1990) 1.44
Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection. Infect Immun (1983) 1.42
Comparison of six methods for detecting human rotavirus in stools. Eur J Clin Microbiol (1984) 1.40
Acute brain death abolishes the cardioprotective effects of ischemic preconditioning in the rabbit. Transplantation (2000) 1.39
The immunology of leprosy: speculations on the leprosy spectrum. Rev Infect Dis (1981) 1.38
Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. I. Depression of the afferent arc. J Immunol (1975) 1.37
HIV-1 sensitivity to zidovudine: a consensus culture technique validated by genotypic analysis of the reverse transcriptase. J Virol Methods (1992) 1.34
Plasmid-mediated rifampin resistance encoded by an arr-2-like gene cassette in Klebsiella pneumoniae producing an ACC-1 class C beta-lactamase. Antimicrob Agents Chemother (2001) 1.31
Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: prevalence and clinical and biologic features. J Infect Dis (1993) 1.30
Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase. FEMS Microbiol Lett (1994) 1.30
Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships. J Infect Dis (2000) 1.25
Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice. Clin Exp Immunol (1979) 1.24
Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. J Virol (1997) 1.24
Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection. Ann Immunol (Paris) (1980) 1.23
Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains. Ann Immunol (Paris) (1983) 1.23
Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status. J Clin Microbiol (1999) 1.22
The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine. J Biol Stand (1988) 1.12
Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. II. Stimulation of the efferent arc. J Immunol (1975) 1.11
Human parvovirus infections in France. Lancet (1984) 1.09
Sodium dodecyl sulfate-agarose gel electrophoresis of urinary proteins: application to multiple myeloma. Clin Chem (1998) 1.08
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Site of action of serum factors that block delayed-type hypersensitivity in mice. J Exp Med (1978) 1.07
Complex segregation analysis of leprosy in southern Vietnam. Genet Epidemiol (1995) 1.06
Comparative in vitro activities of pristinamycin, its components, and other antimicrobial agents against anaerobic bacteria. Antimicrob Agents Chemother (1988) 1.04
Stavudine resistance: an update on susceptibility following prolonged therapy. Antivir Ther (1999) 1.04
Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine. J Infect Dis (2001) 1.03
IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients. Clin Exp Immunol (1998) 1.03
[Osteoarthritis caused by dematiaceous fungi. Apropos of 3 cases]. Ann Med Interne (Paris) (1985) 1.03
Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis (1996) 1.01
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over study. Antivir Ther (1999) 1.01
Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF). Transplantation (1999) 1.00
Effect of josamycin on plasma cyclosporine levels. Eur J Clin Pharmacol (1987) 1.00
(1)H NMR-based metabolomics approach for exploring urinary metabolome modifications after acute and chronic physical exercise. Anal Bioanal Chem (2009) 0.99
Systemic candidiasis in mice. I.--Correlation between kidney infection and mortality rate. Ann Immunol (Paris) (1980) 0.99
Kinetics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy. Tuber Lung Dis (2000) 0.99
Immunological behavior after mycobacterial infection in selected lines of mice with high or low antibody responses. Infect Immun (1979) 0.98
Delayed-type hypersensitivity to rabies virus in mice: assay of active or passive sensitization by the footpad test. Infect Immun (1978) 0.98
Different time course patterns of local expression of delayed-type hypersensitivity to sheep red blood cells in mice. Cell Immunol (1992) 0.98
Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice. Infect Immun (1984) 0.97
Restoration of cell-mediated immunity to animals blocked by a humoral response. J Exp Med (1974) 0.96
Focal segmental glomerulosclerosis associated with mitochondrial cytopathy. Kidney Int (2000) 0.96
In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors. J Antimicrob Chemother (1996) 0.96
Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemurium. Cell Immunol (1985) 0.96
Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients. J Clin Microbiol (1989) 0.95
[Delayed local reaction (DLR) after BCG vaccination in mice. II.--Correlations with the immune response (author's transl)]. Ann Immunol (Paris) (1978) 0.94
A one-year prospective study (1994-1995) for a first evaluation of tuberculosis transmission in French prisons. Int J Tuberc Lung Dis (2000) 0.94
Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection. Ann Intern Med (1989) 0.94
Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice. Clin Exp Immunol (1989) 0.93
Astrovirus enteritis in a chronic lymphocytic leukemia patient treated with fludarabine monophosphate. Ann Hematol (2000) 0.92
Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins. Antimicrob Agents Chemother (1993) 0.92
Inclusion-body myositis: clinicopathological studies and isolation of an adenovirus type 2 from muscle biopsy specimen. Ann Neurol (1982) 0.92
Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation. Transplantation (1991) 0.92
Delayed-type hypersensitivity and acquired resistance to plague in mice immunized with killed Yersinia pestis and immunoregulators. Immunology (1981) 0.92
Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization. Kidney Int (1979) 0.91
Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron (1993) 0.91
Simultaneous progressive multifocal leukoencephalopathy, Epstein-Barr virus (EBV) latent infection and cerebral parenchymal infiltration during chronic lymphocytic leukemia. Leukemia (1994) 0.91
Immunological mechanisms controlling mycobacterial infections. Bull Eur Physiopathol Respir (1983) 0.91
[Inflammation and resistance of mice infected by "Candida albicans" (author's transl)]. Ann Immunol (Paris) (1979) 0.90
Modulation by malaria infection of the induction of T lymphocyte-dependent delayed-type hypersensitivity and antibody formation to sheep erythrocytes in mice. Parasite Immunol (1979) 0.90
In vivo detection of specific cell-mediated immunity in street rabies virus infection in mice. J Gen Virol (1980) 0.90
Comparative assessment of quantitative HIV viraemia assays. AIDS (1992) 0.90
Synergic inhibitory activity of amphotericin-B and gamma interferon against intracellular Cryptococcus neoformans in murine macrophages. J Antimicrob Chemother (1994) 0.89
Short-term evaluation of zidovudine-treated patients: decrease in plasma and cellular viraemia titres. AIDS (1992) 0.89
Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines. Br J Cancer (1992) 0.89
Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression. AIDS (1994) 0.88
Is renal transplantation involved in post-transplantation liver disease? A prospective study. Transplantation (1980) 0.88
Hodgkin's disease after transplantation. Transplantation (1996) 0.88
Circulating immune complexes in human tuberculosis sera: demonstration of specific antibodies against Mycobacterium tuberculosis glycolipid (DAT, PGLTb1, LOS) antigens in isolated circulating immune complexes. Eur J Clin Invest (1997) 0.88
In vivo antitumor activity of various forms of delayed-type hypersensitivity in mice. J Natl Cancer Inst (1979) 0.88